Fundz Deep Dive

Everything you need to win Azitra — in one platform.

Who to reach, what to say, and why now on Azitra — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Azitra — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply

Grounded in signals no one else has — tuned to their persona.

Signals no one else has

UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.

Verified contact + click-to-call

The decision-maker’s email and mobile — dial in-browser.

Azitra Announces Share Purchase Agreement with Alumni Capital for $20 Million Funding Partnership

Apr 24, 2025•about 1 year ago

Contract Type

partnership

BranfordBiotechnologyTherapeutics

Description

Azitra, Inc. has entered into a share purchase agreement (SPA) with Alumni Capital LP (Alumni) to fund its clinical pipeline for live biotherapeutic precision products to treat rare and severe dermatologic conditions. This partnership is expected to provide Azitra with a flexible source of funding, enabling the company to progress its pipeline while minimizing dilution and creating shareholder value.

Company Information

Company

Azitra

Location

21 BUSINESS PARK DRIVE, SUITE 6

Branford, Connecticut, United States

About

Azitra is a clinical-stage biopharmaceutical company developing precision dermatology therapies using engineered strains of S. epidermidis. Its lead program, ATR-12, is in a Phase 1b trial for Netherton syndrome, a rare and life-threatening skin disease with no approved treatments. Azitra is also advancing ATR-04, currently in a Phase 1/2 trial, to treat EGFR inhibitor–associated skin toxicity, a condition affecting roughly 150,000 people in the U.S. Supported by a proprietary platform of engineered proteins, live biotherapeutics, and an AI-enhanced microbial library of 1,500 strains, Azitra is pioneering targeted, innovative solutions for severe dermatologic needs.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence

Strategic

ML-powered predictions for Azitra's next move

Learn about Strategic plan

Agreement Insights

Based on industry data

Strategic partnership established

Partnership agreements typically involve technology integration and joint go-to-market strategies

Contract momentum indicator

Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months